跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Butaprev - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Butaprev
Approved
STANDARD
Butaprev
Cipla Ltd. - Unit I
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5e8d066c6c8de463
Company
Cipla Ltd. - Unit I
Type
Standard
Approval Details
Approval Id
5e8d066c6c8de463
Drug Approval Philippines Name
Butaprev
Product Name
Butaprev
Registration Number
DRP-14861
Brand Name
Butaprev
Generic Name
Salbutamol (as sulfate)
Dosage Form
Solution for Nebulization.
Dosage Strength
1 mg/mL (2.5 mg/2.5 mL)
Manufacturer
Cipla Ltd. - Unit I
Importer
SMHP Pharmaceuticals Incorporated
Distributor
SMHP Pharmaceuticals Incorporated
Issuance Date
26 July 2024
Expiry Date
25 January 2029
Pharmacologic Category
Antiasthma
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5e8d066c6c8de463
Type
Standard
Back to Philippines FDA Approvals